Enzymes help speed up chemical reactions in the body. They control everything from digesting food, to muscle growth, to blood ...

Peytant Solutions announced today that the FDA granted marketing authorization for its AMStent tracheobronchial covered stent ...

This fall, the federal government is offering a new round of free COVID-19 tests, but many of the tests arriving in mailboxes ...

The FDA has granted a de novo clearance to a new type of stent designed to hold open the passages down the windpipe and into ...

A spokesperson for federal prosecutors says former Abercrombie & Fitch CEO Michael Jeffries and two other men have been ...

Soda, chips, cookies—brands are turning the stuff we used to consider junk food into nutritionally awesome upgrades. Or so ...

Antidepressants, the gold standard treatment for depression, don’t work for many people. Will psilocybin be an alternative?

The FDA issued a complete response letter (CRL) to Camurus, dealing a setback to the Swedish drugmaker’s efforts to bring its ...

Bose gave up on Sleepbuds after two generations. It was a sad, premature end for a promising product. The headphone maker ...

In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the ...

Advocates argue that anti-obesity drugs like Ozempic could help overweight troops, but the services have no uniform policy ...

NanoViricides, Inc. (NYSE Amer.: NNVC ) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...